Screening for thyroid disease in pregnancy: A review

Minerva Ginecologica

Volumn 65, Issue 4, 2013, Pages 471-484

  Cassar, N J ^a   Grima, A P ^a   Ellul, G J ^a   Schembri Wismayer, P ^a   Calleja Agius, J ^a,b  

^a UNIVERSITY OF MALTA   (Malta)

^b MATER DEI HOSPITAL   (Malta)

Author keywords

Allergy and immunology; Anti thyroglobulin; Diagnosis; Epidemiology; Hyperthyroidism; Hypothyroidism; Mass screening

Indexed keywords

AUTOANTIBODY; CHORIONIC GONADOTROPIN; IODINE; LIOTHYRONINE; SELENIUM; THYROID ANTIBODY; THYROTROPIN; THYROXINE; WATER; THYROID HORMONE;

FOOD; FREE LIOTHYRONINE INDEX; GRAVES DISEASE; HASHIMOTO DISEASE; HORMONE BLOOD LEVEL; HUMAN; HYPEREMESIS GRAVIDARUM; INFORMATION DISSEMINATION; IODINE DEFICIENCY; MOTHER; POSTPARTUM THYROIDITIS; PRACTICE GUIDELINE; PREGNANCY; PREVALENCE; PROGENY; PUERPERIUM; REVIEW; SCREENING; SELENIUM DEFICIENCY; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; ULTRASOUND; ABORTION, SPONTANEOUS; BLOOD; DEFICIENCY; DIETARY REFERENCE INTAKE; ECHOGRAPHY; FEMALE; FETAL DISEASES; MASS SCREENING; NEWBORN; NEWBORN SCREENING; PREGNANCY COMPLICATIONS; PRENATAL CARE; PRENATAL DIAGNOSIS; PROCEDURES; PUERPERAL DISORDERS; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; THYROID DISEASES; THYROID GLAND;

ABORTION, SPONTANEOUS; AUTOANTIBODIES; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; IODINE; MASS SCREENING; NEONATAL SCREENING; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; PRENATAL DIAGNOSIS; PUERPERAL DISORDERS; RECOMMENDED DIETARY ALLOWANCES; REFERENCE VALUES; SELENIUM; SENSITIVITY AND SPECIFICITY; THYROID DISEASES; THYROID GLAND; THYROID HORMONES; THYROTROPIN;

EID: 84887479516     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002;8:457-69.
2. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007,92(8 Suppl):S1-47.
3. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and post-partum. Thyroid 2011;21:1081-125.
4. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical Thyroid Dysfunction:A Joint Statement on Management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab 2005;90:581-5. (Pubitemid 40116712)
5. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006;91:2587-91. (Pubitemid 44024622)
6. Dosiou C, Sanders GD, Araki SS, Crapo LM. Screening pregnant women for autoimmune thyroid disease:a cost-effectiveness analysis. Eur J Endocrinol 2008;158:841-51. (Pubitemid 351837373)
7. Horacek J, Spitalnikova S, Dlabalova B, Malirova E, Vizda J, Svilias I et al. Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding. Eur J Endocrinol 2010;163:645-50.
8. Adlan MA, Premawardhana LD. Thyroid peroxidase antibody and screening for postpartum thyroid dysfunction. J Thyroid Res. Epub 2011 10, accessed 2011 8;2011:745135.
9. Stagnaro-Green A. Clinical review 152:Postpartum thyroiditis. J Clin Endocrinol Metab 2002,87:4042-7.
10. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228-38. (Pubitemid 38082818)
11. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 2010;1;95:1699-707.
12. Raffle AE, Muir Gray JA. Screening Evidence and practice. New York: Oxford University Press; 2007.
13. Petros M. Revisiting the Wilson-Jungner criteria: How can supplemental criteria guide public health in the era of genetic screening? Genet Med 2012;14:129-34.
14. Programme appraisal criteria: Criteria for appraising the viability, effectiveness and appropriateness of a screening programme [Internet], United Kingdom:UK National Screening Committee;c2011 [updated 2011 8; cited 2011 8], Available at: http://www.screening.nhs.uk/criteria
15. Wilson JM, Jungner YG. Principles and practice of screening for disease. Geneva: World Health Organisation; 1968.
16. Nicholson WK, Robinson KA, Smallridge RC, Ladenson PW, Powe NR. Prevalence of Postpartum Thyroid DysfunctiomA Quantitative Review. Thyroid 2006;16:573-82. (Pubitemid 44066264)
17. Amino N, Tada H, Hidaka Y, Crapo LM, Stagnaro-Green A. Therapeutic Controversy:Screening for Postpartum Thyroiditis. J Clin Endocrinol Metab 1999;84:1813-21.
18. Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 2001 1;22:605-30.
19. Kokandi AA, Parkes AB, Premawardhana LD, John R, Lazarus JH. Association of postpartum thyroid dysfunction with antepartum hormonal and immunological changes. J Clin Endocrinol Metab 2003;88:1126-32. (Pubitemid 36337766)
20. Jaén Díaz JI, López De Castro F, Cordero García B, Santillana Balduz F, Sastrecos J, Martín Dal Gesso C. Incidence of postpartum thyroiditis and study of possible associated factors. Med Clin (Barc) 2009 25;132:569-73.
21. Lazarus JH, Premawardhana LDKE. Screening for thyroid disease in pregnancy. J Clin Pathol 2005;58:449-52. (Pubitemid 40646862)
22. Lazarus JH, Ammari F, Oretti R, Parkes AB, Richards CJ, Harris B. Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract 1997;47:305-8. (Pubitemid 27208113)
23. Postpartum Thyroiditis [web brochure]. Virginia: American Thyroid Association;c2005 [updated 2010 15, cited 2011 08]. Available from: http://www.thyroid.org/patients/brochures/Postpartum-Thyroiditis-brochure.pdf [cited 2012 Nov 13].
24. Männistö T, Väärasmäki M, Pouta A, Hartikainen AL, Ruokonen A, Surcel HM et al. Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J Clin Endocrinol Metab 2010 1;95:1084-94.
25. Lazarus JH. Screening for thyroid dysfunction in pregnancy: is it worthwhile? J Thyroid Res. J Thyroid Res 2011;2011:397012.
26. Klubo-Gwiezdzinska J, Burman KD, Van Nostrand D, Wartofsky L. Levothyroxine treatment in pregnancy: indications, efficacy, and therapeutic regimen. J Thyroid Res 2011;2011:843591.
27. Milanesi A, Brent GA. Management of hypothyroidism in pregnancy. Curr Opin Endocrinol Diabetes Obes 2011;18:304-9.
28. De Vivo A, Mancuso A, Giacobbe A, Moleti M, Maggio Savasta L, De Dominici R et al. Thyroid function in women found to have early pregnancy loss. Thyroid 2010;20:633-7.
29. Reid SM, Middleton P, Cossich MC, Crowther CA. Interventions for clinical and subclinical hypothyroidism in pregnancy. Cochrane Database Syst Rev 2010 7;:CD007752.
30. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ et al. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006;107:337-41.
31. Marx H, Amin P, Lazarus JH. Hyperthyroidism and pregnancy. BMJ 2008;336:663-7.
32. Galofre JC, Davies TF. Autoimmune Thyroid Disease in Pregnancy:A Review. J Womens Health (Larchmt) 2009;18:1847-56.
33. Azizi F, Amouzegar A. Management of hyperthyroidism during pregnancy and lactation. Eur J Endocrinol 2011;164:871-6.
34. Thyroid Disease Manager. Homepage [Internet], Massachusetts: Endocrine Education, Inc.;c2008 [2011, Oct 10]. Lazarus JH. (Chapter 14) Thyroid Regulation and Dysfunction in the Pregnant Patient. Updated 2011, cited 2011 10. Available at http://www.thyroidmanager.org/ [cited 2012, Nov 13].
35. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3-126.
36. Bonds DE, Freedberg KA. Cost-effectiveness of prenatal screening for postpartum thyroiditis. J Womens Health Gend Based Med 2001;10:649-58. (Pubitemid 32976202)
37. Mbah AU, Ejim EC, Onodugo OD, Ezugwu FO, Eze MI, Nkwo PO et al. Two logistic models for the prediction of hypothyroidism in pregnancy. BMC Res Notes 2011;4:205.
38. Mandel SJ, Spencer CA, Hollowell JG. Are detection and treatment of thyroid insufficiency in pregnancy feasible? Thyroid 2005;15:44-53. (Pubitemid 40223500)
39. Springer D, Zima T, Limanova Z. Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy. Eur J Endocrinol 2009 1;160:791-7.
40. Feldt-Rasmussen U, Bliddal Mortensen AS, Rasmussen AK, Boas M, Hilsted L, Main K. Challenges in interpretation of thyroid function tests in pregnant women with autoimmune thyroid disease. J Thyroid Res 2011 [Epub ahead of print],
41. Gilbert RM, Hadlow NC, Walsh JP, Fletcher SJ, Brown SJ, Stuckey BG et al. Assessment of thyroid function during pregnancy: first-trimester (weeks 9-13) reference intervals derived from Western Australian women. Med J Aust 2008;189:250-3.
42. Vaidya B, Anthony S, Bilous M, Shields B, Drury J, Hutchison S et al. Detection of thyroid dysfunction in early pregnancy:Universal screening or targeted high-risk case finding? J Clin Endocrinol Metab 2007;92:203-7. (Pubitemid 46067531)
43. ThyroidToday [homepage on the Internet]. Illinois: Academy for Continued Healthcare Learning;c2011 [updated 2004 26; cited 2011 8]. Wartofsky L. Antepartum Thyroid Disease Diagnosis and Management;[7 pages]. Available at: http://www.thyroidtoday.com/ExpertOpinionsl.asp [cited 2012, Nov 13].
44. Thung SF, Funai EF, Grobman WA. The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism. Am J Obstet Gynecol 2009;200:267.e1-267.e7.
45. Lee RH, Spencer CA, Mestman JH, Miller EA, Petrovic I, Braverman LE et al. Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol 2009;200:260.e1-260e.6.
46. Joshi SR. Laboratory evaluation of thyroid function. J Assoc Physicians India 2011;59(Suppl): 14-20.
47. Munsakul N, Suraamornkul S, Rawdaree P. Prevalence of T3 toxicosis and FT4 toxicosis in Thyrotoxic Patients. Vajira Med J 2001;45:55-60.
48. Smallridge RC. Postpartum thyroid disease A model of immunologic dysfunction. Clin Appl Immunol Rev 2000;1:89-103.
49. Saranac L, Zivanovic S, Bjelakovic B, Stamenkovic H, Novak M, Kamenov B. Why is the thyroid so prone to autoimmune disease? Horm Res Paediatr 2011;75:157-65.
50. Kamijo K. TSH-receptor antibodies determined by the first, second and third generation assays and thyroid-stimulating antibody in pregnant patients with Graves' disease. Endocr J 2007;54:619-24. (Pubitemid 47414612)
51. Zaletel K. Determinants of thyroid autoantibody production in Hashimotos thyroiditis. Expert Rev Clin Immunol 2007;3:217-23.
52. Lucas A, Pizarro E, Granada ML, Salinas I, Roca J, Sanmartí A. Postpartum thyroiditis: long-term follow-up. Thyroid 2005;15:1177-81. (Pubitemid 41720725)
53. Stuckey BG, Kent GN, Ward LC, Brown SJ, Walsh JP. Postpartum thyroid dysfunction and the long-term risk of hypothyroidism: results from a 12-year follow-up study of women with and without post-partum thyroid dysfunction. Clin Endocrinol (Oxf) 2010;73:389-95.
54. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 2011 9;342:d2616.
55. Lambrinoudaki I, Rizos D, Armeni E, Pliatsika P, Leonardou A, Sygelou A et al. Thyroid function and postpartum mood disturbances in Greek women. J Affect Disord 2010;121:278-82.
56. Kuijpens JL, Vader HL, Drexhage HA, Wiersinga WM, van Son MJ, Pop VJ. Thyroid peroxidase antibodies during gestation are aker for subsequent depression postpartum. Eur J Endocrinol 2001;145:579-84. (Pubitemid 33061903)
57. Wasserman EE, Nelson K, Rose NR, Eaton W, Pillion JP, Seaberg E et al. Maternal thyroid autoantibodies during the third trimester and hearing deficits in children: an epidemiologic assessment. Am J Epidemiol 2008;167:701-10. (Pubitemid 351430928)
58. Marwaha RK, Chopra S, Gopalakrishnan S, Sharma B, Kanwar RS, Sastry A et al. Establishment of reference range for thyroid hormones in normal pregnant Indian women. BJOG 2008;115:602-6. (Pubitemid 351357586)
59. Greer LG, Casey BM, Halvorson LM, Spong CY, McIntire DD, Cunningham FG. Antithyroid antibodies and parity: further evidence for microchimerism in autoimmune thyroid disease. Am J Obstet Gynecol 2011;205:471.e1-471e.4.
60. Glinoer D, Spencer CA. Serum TSH determinations in pregnancy: how, when and why? Nat Rev Endocrinol 2010;6:526-9.
61. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA et al. Serum TSH, T, and thyroid antibodies in the United States population (1988 to 1994):National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002 1;87:489-99.
62. Matalon ST, Blank M, Levy Y, Carp HJ, Arad A, Burek L et al. The pathogenic role of anti-thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice. Hum Reprod 2003;18:1094-9. (Pubitemid 36592055)
63. Shoenfeld Y, Carp HJ, Molina V, Blank M, Cervera R, Balasch J et al. Autoantibodies and prediction of reproductive failure. Am J Reprod Immunol 2006;56:337-44. (Pubitemid 44669330)
64. Weetman AP. Graves' disease. N Engl J Med 2000 26;343:1236-48.
65. Patil-Sisodia K, Mestman JH. Graves hyperthyroidism and pregnancy:a clinical update. Endocr Pract 2010;16:118-29.
66. Rotondi M, Pirali B, Lodigiani S, Bray S, Leporati P, Chytiris S et al. The post partum period and the onset of Graves' disease: an overestimated risk factor. Eur J Endocrinol 2008 1;159:161-5.
67. Zimmermann MB. Iodine deficiency in pregnancy and the effects of maternal iodine supplementation on the offspring: a review. Am J Clin Nutr 2009;89:668S-672S.
68. Azizi F, Aminorroya A, Hedayati M, Rezvanian H, Amini M, Mirmiran P. Urinary iodine excretion in pregnant women residing in areas with adequate iodine intake. Public Health Nutr 2003;6:95-8. (Pubitemid 36232174)
69. Current Controlled Trials. Homepage. [Internet], Berlin: Springer Science+Business Media; c2011 [updated 2011 12, cited 2011 8]. Controlled Antenatal Thyroid Screening study. Available at: http://www.controlledtrials. com/ISRCTN46178175 [cited 2012, Nov 13].
70. Lazarus JH. Investigations of Neurodevelopmental Outcome in Infants and Children Born to Women with Thyroid Dysfunction. Impact of Maternal Thyroid Status on Pregnancy and Fetal and Childhood Development: A Symposium of the American Thyroid Association and the American Association of Clinical Endocrinologists; 2004 2 Available at http://site.blueskybroadcast.com/Client/ ATA-4.2.04/ [cited 2012, Nov 13].
71. Sullivan MG. Antenatal thyroid screen didn't affect offspring's IQ. Ob Gyn News 2010;45:2.
72. Negro R. Thyroid insufficiency during pregnancy: complications and implications for screening. Expert Rev Endocrinol Metab 2008 1;3:137-46.
73. Allan WC, Haddow JE, Palomaki GE, Williams JR, Mitchell ML, Hermos RJ et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 2000 1;7:127-30.
74. Huel C, Guibourdenche J, Vuillard E, Ouahba J, Piketty M, Oury JF et al. Use of ultrasound to distinguish between fetal hyperthyroidism and hypothyroidism on discovery of a goiter. Ultrasound Obstet Gynecol 2009;33:412-20.
75. Koyuncu FM, Tamay AG, Bugday S. Intrauterine diagnosis and management of fetal goiter:a case report. J Clin Ultrasound 2010-Dec;38:503-505.
76. Grüters A, Krude H. Detection and treatment of congenital hypothyroidism. Nat Rev Endocrinol 2011;8:104-13.
77. Rapaport R. Congenital hypothyroidism: an evolving common clinical conundrum. J Clin Endocrinol Metab 2010;95 4223-5.
78. Hashemipour M, Dehkordi EH, Hovsepian S, Amini M, Hosseiny L. Outcome of congenitally hypothyroid screening program in Isfahan:Iran from prevention to treatment. Int J Prev Med 2010;1:92-7.
79. Ng SM, Wong SC, Paize F, Chakkarapani E, Newland P, Isherwood D et al. Multivariate analyses of factors that affect neonatal screening thyroid stimulating hormone. J Pediatr Endocrin Met 2011;24:727-32.
80. Hallett A, Evans C, Moat S, Barton J, Warner J, Gregory JW. Hypothyroidism in preterm infants following normal screening. Ann Clin Biochem 2011;48(Pt 6): 572-4.
81. Zimmermann MB, Köhrle J. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid 2002;12:867-78. (Pubitemid 35332991)
82. Alvarez-Pedrerol M, Guxens M, Mendez M, Canet Y,torell R, Espada M et al. Iodine levels and thyroid hormones in healthy pregnant women and birth weight of their offspring. Eur J Endocrinol 2009;160:423-9.
83. Verger P, Aurengo A, Geoffrey B, Le Guen B. Iodine kinetics and effectiveness of stable iodine prophylaxis after intake of radioactive iodine:a review. Thyroid 2001;11:353-60. (Pubitemid 32422627)
84. Delange F, Bourdoux P, Vo Thi LD, Ermans AM, Senterre J. Negative iodine balance in preterm infants. Ann Endocrinol 1984;45:77.
85. Azizi F, Smyth P. Breastfeeding and maternal and infant iodine nutrition. Clin Endocrinol (Oxf) 2009;70:803-9.
86. Thyroid Disease and Pregnancy [web brochure]. Virginia: American Thyroid Association;c2005 [updated 2010 15, cited 2011 8]. Available at: http://www.thyroid.org/patients/brochures/Thyroid-Dis-Pregnancy-broch.pdf [cited 2012, Nov 13].
87. Thyroid Disease Manager. Homepage. Massachussetts: Endocrine Education, Inc.;c2008 [updated 2011 10, cited 2011 10]. Brown RS. (Chapter 15b) Disorders of the Thyroid Gland in Infancy, Childhood and Adolescence. Available at: http://www.thyroidmanager. org/ [cited 2012, Nov 13].
88. Better Health Channel. Iodine explained [webpage]. Victoria: State Government of Vicotira; c2011 Available at: http://www.betterhealth.vic.gov.au/ bhcv2/bhcarticles.nsf/pages/iodine-explained [cited 2012, Nov 13].
89. Office of Dietary Supplements National Institutes of Health. Dietary supplement fact sheet: selenium [webpage]. Available at: http://ods.od.nih.gov/ factsheets/selenium [cited 2012, Nov 13].
90. Moleti M, Lo Presti VP, Mattina F, Mancuso A, De Vivo A, Giorgianni G et al. Gestational thyroid function abnormalities in conditions of mild iodine deficiency: early screening versus continuous monitoring of maternal thyroid status. Eur J Endocrinol 2009 1;160:611-7.
91. Thyroid Disease Manager. Homepage. Massachusetts: Endocrine Education, Inc.; c2008. Eastman CJ, Zimmermann MB. (Chapter 20) The Iodine Deficiency Disorders. Updated 2009 1, cited 2011 10. Available from: http://www. thyroidmanager.org/ [cited 2012, Nov 13].
92. American Thyroid Association. Consensus Statement #2:American Thyroid Association statement on early maternal thyroidal insufficiency: recognition, clinical management and research directions. Thyroid 2005;15:77-9.
93. Ayala AR, Wartofsky L. The case for more aggressive screening and treatment of mild thyroid failure. Cleve Clin J Med 2002;69:313-20. (Pubitemid 34436316)
94. Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. BMJ 1996;313:539-44. (Pubitemid 26336143)
95. Stagnaro-Green A. Can a high-risk case-finding approach identify all women with thyroid dysfunction during pregnancy? Nat Clin Pract Endocrinol Metab 2007;3:216-7.
96. Wang W, Teng W, Shan Z, Wang S, Li J, Zhu L et al. The prevalence of thyroid disorders during early pregnancy in China: the benefits of universal screening in the first trimester of pregnancy. Eur J Endocrinol 2011;164:263-8.
97. Chang DL, Leung AM, Braverman LE, Pearce EN. Thyroid testing during pregnancy at an academic Boston Area Medical Center. J Clin Endocrinol Metab 2011;96:E1452-E1456.
98. Stagnaro-Green A, Schwartz A. Is universal screening for thyroid disease in pregnancy a cost-effective strategy? Nat Clin Pract Endocrinol Metab 2008;4:598-9.